0001193125-13-480884.txt : 20140425 0001193125-13-480884.hdr.sgml : 20140425 20131220152833 ACCESSION NUMBER: 0001193125-13-480884 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20131220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-242-3700 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 CORRESP 1 filename1.htm Correspondence
  

David Tyronne Howton

Sandesh Mahatme

Sarepta Therapeutics, Inc.

215 First Street, Suite 7,

Cambridge, MA 02142

December 20, 2013

VIA EDGAR

Securities and Exchange Commission

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Jim B. Rosenberg

 

  Re: Sarepta Therapeutics, Inc.

Form 10-K for Fiscal Year Ended December 31, 2012

Filed March 15, 2013

Form 10-Q for the Quarterly Period Ended June 30, 2013

Filed August 8, 2013

File No. 001-14895

Dear Mr. Rosenberg:

Pursuant to our phone conversation with Matthew Jones, Staff Attorney, on December 20, 2013, where we requested an extension to January 6, 2014 for Sarepta Therapeutics, Inc. (the “Company”) to submit its response (the “Response”) to the comments of the staff (the “Staff”) of the Securities Exchange Commission in its letter dated November 25, 2013 (the “Comment Letter”), and the grant of such request by Mr. Jones, the Company will file its Response to the Comment Letter on or before January 6, 2014.

We thank the Staff for its understanding and flexibility.

Please do not hesitate to contact me at 1-857-242-3708 or THowton@Sarepta.com, with a copy to SMahatme@Sarepta.com, with any questions or comments you may have.

 

Very truly yours,

/s/ David Tyronne Howton

Name: David Tyronne Howton
Title: Sr. VP, General Counsel

 

cc: Sandesh Mahatme